共 56 条
[1]
Spira A.(2004)Multidisciplinary management of lung cancer N Engl J Med 350 379-392
[2]
Ettinger D.S.(2004)American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 330-353
[3]
Pfister D.G.(1996)Improved survival in stage III non-small-cell lung cancer: 7-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1210-1215
[4]
Johnson D.H.(2000)Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 358-364
[5]
Azzoli C.G.(1995)Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer J Clin Oncol 13 452-458
[6]
Dillman R.O.(1999)Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692-2699
[7]
Herndon J.(2003)Phase III comparison of sequential vs concurrent chemoradiotherapy for pts with unresected stage III non-small cell lung cancer (NSCLC): report of Radiation Therapy Oncology Group (RTOG) 9410 (abstract) Proc Am Soc Clin Oncol 22 2499-1100
[8]
Seagren S.L.(1998)New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions Clin Cancer Res 4 1087-485
[9]
Sause W.(2000)Lung cancer Lancet 355 479-61
[10]
Kolesar P.(2004)Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese Taxotere Lung Cancer Study Group J Clin Oncol 22 254-367